VOGLINORM GM 2 TAB

About

Voglinorm GM 2 Tab is a combination medication designed for the comprehensive management of type 2 diabetes mellitus, integrating the actions of Voglibose, Glibenclamide, and Metformin. Voglibose, an alpha-glucosidase inhibitor, works by delaying the digestion and absorption of carbohydrates in the small intestine, thereby significantly reducing post-prandial (after-meal) blood glucose spikes. Glibenclamide, a sulfonylurea, stimulates the pancreatic beta cells to release more insulin, which helps to lower blood sugar levels throughout the day.

Metformin, a biguanide, acts primarily by decreasing glucose production in the liver and improving insulin sensitivity in peripheral tissues, allowing the body to use insulin more effectively. This triple-action approach targets multiple pathophysiological defects in type 2 diabetes, offering robust glycemic control. The synergistic effects of these three agents help to achieve and maintain target blood glucose levels, reduce HbA1c, and mitigate the risk of long-term diabetes complications, making it a potent option for patients requiring intensive glycemic management.

Uses

• Management of type 2 diabetes mellitus.
• Improved glycemic control in adults.
• Reduction of post-prandial hyperglycemia.
• Used when monotherapy or dual therapy is insufficient.

Directions For Use

Take this medication orally, usually with meals, as directed by your healthcare provider. Swallow the tablet whole with water.

Benefits

• Provides comprehensive blood sugar control.
• Targets both fasting and post-meal glucose levels.
• Reduces HbA1c effectively.
• Combines three distinct mechanisms of action.
• Helps prevent long-term diabetes complications.
• Offers a convenient single-tablet regimen.

Side Effects

• Hypoglycemia (low blood sugar)
• Nausea
• Diarrhea
• Abdominal pain
• Flatulence
• Headache
• Dizziness
• Metallic taste in mouth
• Skin rash
• Weight gain (due to Glibenclamide)
• Lactic acidosis (rare, serious with Metformin)
• Vitamin B12 deficiency (long-term Metformin use)

Safety Measures

• Alcohol - Alcohol can increase the risk of hypoglycemia and lactic acidosis (with Metformin). Limit or avoid alcohol consumption.
• Pregnancy - Generally not recommended during pregnancy. Insulin is often preferred for glycemic control in pregnant diabetic women. Consult your doctor.
• Breastfeeding - Avoid use during breastfeeding as components may pass into breast milk and affect the infant.
• Liver - Use with caution in patients with liver impairment, especially due to Metformin and Glibenclamide. Regular monitoring is advised.
• Kidney - Contraindicated in severe renal impairment due to Metformin's risk of lactic acidosis. Dose adjustment is necessary for moderate impairment.
• Lung - No specific contraindications related to lung conditions, but severe respiratory failure can increase lactic acidosis risk with Metformin.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.